Drug Shortage Report for PMS-DICLOFENAC-MISOPROSTOL
Report ID | 88034 |
Drug Identification Number | 02413469 |
Brand name | PMS-DICLOFENAC-MISOPROSTOL |
Common or Proper name | DICLOFENAC-MISOPROSOL |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | MISOPROSTOL DICLOFENAC SODIUM |
Strength(s) | 200MCG 50MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL |
Packaging size | 70 |
ATC code | M01AB |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-06-25 |
Actual start date | |
Estimated end date | 2019-10-28 |
Actual end date | 2019-09-03 |
Shortage status | Resolved |
Updated date | 2019-09-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-06-28 | English | Compare |
v2 | 2019-06-28 | French | Compare |
v3 | 2019-09-04 | English | Compare |
v4 | 2019-09-04 | French | Compare |
Showing 1 to 4 of 4